Sandra Perez Baos

Associate

2024 - Current

Analyst

2023 - 2024

2048 Ventures is a thesis-driven earliest stage venture capital firm. We are the first-check, high conviction, lead investor backing founders who are building businesses differentiated through data and technology. We focus on Biotechnology, Digital Health, AI/ML, Robotics, AR/VR, IoT, Hardware, Climate, Energy, Space, Mobility, Logistics, Security, Developer Tools and other Frontier Tech. We invest in across North America and the UK.

Postdoctoral Research Scientist

2019 - 2023

Immunology | T cells | mRNA translation Provided the basis for precise and specific therapeutic approaches based on translational reprogramming of T cells in cancer and autoimmunity. • Demonstrated strategic planning and execution skills, ensuring timely completion of research ideas, grant proposals, and project milestones while adhering to budgetary constraints. • Implemented cutting-edge research methods in collaboration with team members to enhance research quality. • Managed a transgenic mouse colony of 200+ mice and performed in vivo research. • Successfully secured funding from public and private entities through proactive pursuit of research grants. • Led group meetings and maintained close communication with the team. • Communicated the status of projects to internal and external stakeholders. • Prepared and delivered compelling presentations to disseminate research findings at 3 key scientific conferences. • Published 3 articles in high-impact scientific journals.

Mentor Relations Director • Tech Sourcing Lead

2021 - 2023

Nucleate is a collaborative trainee-run startup accelerator that facilitates the formation of life science companies by aligning PhD, MD, and MBA students with biotech executives, venture capitalists and industry-passionate entrepreneurs. • Identified highly promising academic innovation and conducted due diligence to assess its merit and feasibility for participation in Nucleate’s venture creation program. • Developed and maintained key relationships with collaborating advisors (academics, founders, venture capitalists, and C-level executives). • Coordinated the mentor-mentee matching process, ensuring effective pairing of mentors and program participants.

Technology Opportunities & Ventures Intern

2022 - 2023

Contributed to accelerating the path to market of NYU technologies. • Reviewed invention disclosures and patent applications on NYU technologies to further analyze their commercialization potential. • Prepared non-confidential technology summaries for marketing purposes. • Identified and managed outreach to prospective partners that aligned in strategy (pharmaceuticals, biotech, VCs). • Contributed to the traceability of all records pertaining to marketing efforts. • Participated in business meetings resulting from marketing efforts, and in the negotiation process of licensing agreements.

Laboratory Manager and Post-Doctoral Research Scientist

2018 - 2019

• Strategically managed a portfolio of multidisciplinary projects. • Ensured efficient resource allocation and smooth functioning of lab operations. • Supervised and mentored 5 junior team members. • Served as liaison between scientists and physicians, and between junior team members and management.

Ph.D. Student (PFIS Fellowship, ISCIII)

2014 - 2018

My PhD thesis delved into the role of the JAK/STAT pathway on rheumatoid arthritis, with a focus on the close link between lipid metabolism, inflammation, and sarcopenia. By using in vitro and in vivo approaches, this study revealed a crucial function of this signaling cascade on the cholesterol dynamics in the macrophage, and explained one of the main mechanisms underlying dyslipidemia in rheumatoid arthritis. Additionally, we described a compensatory anabolic response in the rheumatoid muscle driven by decreased STAT-3 activation.

Research Assistant

2013 - 2013

Visiting Ph.D. Fellow (M-AES Fellowship, ISCIII)

2018 - 2018

As part of a collaboration with the laboratory of Dr. Ikewaki (Division of Anti-Aging and Vascular Medicine), I determined the effects of JAK/STAT inhibition on reverse cholesterol transport in a mouse model of rheumatoid arthritis.

Undergraduate Research, Immuno-oncology (M.Sc. Thesis)

2011 - 2012

I worked on a nanoparticle-based system of CX3CL1 delivery for cancer immunotherapy in the laboratory of Dr. Domingo F. Barber.

Undergraduate Research, CNS (JAE-intro Fellowship, CSIC)

2010 - 2010

I was a awarded a competitive fellowship by the Spanish National Research Council (CSIC) to join the laboratory of Dr. Coral Sanfeliu Pujol, where I explored the modulation of sirtuin-1 as a preventive therapy against age-associated neurodegeneration and Alzheimer's disease.

Undergraduate Research, Cancer (JAE-intro Fellowship, CSIC)

2009 - 2009

I was a awarded a competitive fellowship by the Spanish National Research Council (CSIC) to join the laboratory of Dr. Atanasio Pandiella, where I assessed in vitro the effects of the PI3K/mTOR inhibitor BEZ235 on ovarian carcinoma.

Volunteer Research Assistant

2009 - 2009

Mutation detection techniques for hereditary breast cancer (Laboratory of Dr. Rogelio Gonzalez Sarmiento).